These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8021775)

  • 1. Surfactant therapy in extremely premature infants.
    Merritt TA
    J Pediatr; 1994 Jul; 125(1):172-3; author reply 173-4. PubMed ID: 8021775
    [No Abstract]   [Full Text] [Related]  

  • 2. Surfactant therapy in extremely premature infants.
    Bose C; McCaffrey M
    J Pediatr; 1994 Jul; 125(1):173; author reply 173-4. PubMed ID: 8021776
    [No Abstract]   [Full Text] [Related]  

  • 3. Survival and follow-up of infants born at 23 to 26 weeks of gestational age: effects of surfactant therapy.
    Ferrara TB; Hoekstra RE; Couser RJ; Gaziano EP; Calvin SE; Payne NR; Fangman JJ
    J Pediatr; 1994 Jan; 124(1):119-24. PubMed ID: 8283360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pumactant and poractant alfa in respiratory distress syndrome.
    Morley C
    Lancet; 2000 Aug; 356(9231):765; author reply 766. PubMed ID: 11085710
    [No Abstract]   [Full Text] [Related]  

  • 5. Outcome at twelve months of adjusted age in very low birth weight infants with lung immaturity: a randomized, placebo-controlled trial of human surfactant.
    Vaucher YE; Harker L; Merritt TA; Hallman M; Gist K; Bejar R; Heldt GP; Edwards D; Pohjavuori M
    J Pediatr; 1993 Jan; 122(1):126-32. PubMed ID: 8419599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Surfactant therapy and scientific support].
    Milerad J
    Lakartidningen; 1994 Feb; 91(8):701-2. PubMed ID: 8189964
    [No Abstract]   [Full Text] [Related]  

  • 7. Pumactant and poractant alfa in respiratory distress syndrome.
    Wardhaugh AD; Matthes JW
    Lancet; 2000 Aug; 356(9231):765-6. PubMed ID: 11085711
    [No Abstract]   [Full Text] [Related]  

  • 8. [Surfactant therapy--no simple truths].
    Milerad J
    Lakartidningen; 1994 Jan; 91(1-2):18-9. PubMed ID: 8289539
    [No Abstract]   [Full Text] [Related]  

  • 9. Surfactant status in preterm neonates recovering from respiratory distress syndrome.
    Verlato G; Cogo PE; Balzani M; Gucciardi A; Burattini I; De Benedictis F; Martiri G; Carnielli VP
    Pediatrics; 2008 Jul; 122(1):102-8. PubMed ID: 18595992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morbidity and mortality of neonatal respiratory failure in China: surfactant treatment in very immature infants.
    Wang H; Gao X; Liu C; Yan C; Lin X; Yang C; Lin Z; Zhu W; Yang Z; Yu F; Qiu Y; Liu X; Zhou X; Chen C; Sun B;
    Pediatrics; 2012 Mar; 129(3):e731-40. PubMed ID: 22331337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surfactant therapy: more evidence of effectiveness.
    Averell C
    Pediatrics; 1995 Mar; 95(3):456. PubMed ID: 7710548
    [No Abstract]   [Full Text] [Related]  

  • 12. Does prophylactic use of bovine surfactant change drug utilization in very premature infants during neonatal period?
    Gortner L; Bernsau U; Hellwege HH; Hieronimi G; Jorch G; Reiter HL
    Dev Pharmacol Ther; 1991; 16(1):1-6. PubMed ID: 1879246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasopharyngeal surfactant administration to prevent neonatal respiratory distress syndrome.
    Fernandes CJ; Horst DA; O'Donovan DJ
    J Perinatol; 2005 May; 25(5):361-2; author reply 363. PubMed ID: 15861205
    [No Abstract]   [Full Text] [Related]  

  • 14. Exogenous surfactant administration during the transport of premature infants.
    Riek KM
    Air Med J; 2004; 23(5):8-9. PubMed ID: 15337930
    [No Abstract]   [Full Text] [Related]  

  • 15. Surfactant. Evolving issues.
    Kattwinkel J
    Clin Perinatol; 1998 Mar; 25(1):17-32. PubMed ID: 9523072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surfactant replacement in preterm infants with respiratory distress syndrome.
    Dani C
    Acta Biomed; 2012; 83 Suppl 1():17-20. PubMed ID: 23029871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Surfactant therapy of premature infants. Complications and mortality are reduced].
    Hjalmarson O
    Lakartidningen; 1993 Nov; 90(45):3938-40. PubMed ID: 8231562
    [No Abstract]   [Full Text] [Related]  

  • 18. Exogenous surfactant therapy for premature infants.
    Boeckling AC
    J Perinat Neonatal Nurs; 1992 Sep; 6(2):59-66. PubMed ID: 1403772
    [No Abstract]   [Full Text] [Related]  

  • 19. Surfactant therapy: past, present and future.
    Speer CP; Sweet DG; Halliday HL
    Early Hum Dev; 2013 Jun; 89 Suppl 1():S22-4. PubMed ID: 23809343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neonatal management of the very low birth weight infant: the use of surfactant.
    Martin GI; Sindel BD
    Clin Perinatol; 1992 Jun; 19(2):461-8. PubMed ID: 1617888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.